Literature DB >> 16142623

[Smoking promotes the formation of peritonsillar abscesses].

G Lehnerdt1, K Senska, M Fischer, K Jahnke.   

Abstract

INTRODUCTION: Smoking has not properly been investigated as a predisposing factor for the development of a peritonsillar abscess.
METHODS: In a retrospective study a group of 541 abscess tonsillectomies--performed in the department of Otorhinolaryngology (University of Duisburg/Essen) between 1994-2003--was retrospectively analysed for smoking habits of the patients. Further on we investigated the influence of smoking on the risk for a postoperative haemorrhage.
RESULTS: Smoking habits of 519/541 were known, 296/519 (57%) were smokers, which is much more than expected with regard to the prevalence of smokers in the German population. Beneath the 2.2% of patients with a postoperative haemorrhage that had to be arrested under general anaesthesia no statistical relation between the occurrence of a postoperative haemorrhage and smoking was found.
CONCLUSION: Smoking could be an important predisposing factor for the development of peritonsillar abscess e. g. due to alteration of the mucosa and microbiological changes. We could not identify a statistical relation between smoking and the risk of a postoperative haemorrhage after tonsillectomy à chaud.

Entities:  

Mesh:

Year:  2005        PMID: 16142623     DOI: 10.1055/s-2005-870289

Source DB:  PubMed          Journal:  Laryngorhinootologie        ISSN: 0935-8943            Impact factor:   1.057


  11 in total

1.  Smoking promotes peritonsillar abscess.

Authors:  Tejs Ehlers Klug; Maria Rusan; Kim Katrine Bjerring Clemmensen; Kurt Fuursted; Therese Ovesen
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-04-09       Impact factor: 2.503

2.  Medical and surgical treatment of peritonsillar, retropharyngeal, and parapharyngeal abscesses.

Authors:  Fred S Herzon; Angela D Martin
Journal:  Curr Infect Dis Rep       Date:  2006-05       Impact factor: 3.725

3.  Cranial tonsillotomy for peritonsillar abscess: what a relief!

Authors:  Jochen P Windfuhr; M Nematian; S Ziogou
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-06-20       Impact factor: 2.503

4.  Gender-specific risk factors in post-tonsillectomy hemorrhage.

Authors:  Annekatrin Coordes; Janina Soudry; Veit Maria Hofmann; Minoo Lenarz
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-06-21       Impact factor: 2.503

5.  Precipitating factors in the pathogenesis of peritonsillar abscess and bacteriological significance of the Streptococcus milleri group.

Authors:  H Hidaka; S Kuriyama; H Yano; I Tsuji; T Kobayashi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-11-18       Impact factor: 3.267

6.  Peritonsillar abscess: remember to always think twice.

Authors:  Jochen P Windfuhr; Alexandra Zurawski
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-03-21       Impact factor: 2.503

7.  Clinical practice guideline: tonsillitis II. Surgical management.

Authors:  Jochen P Windfuhr; Nicole Toepfner; Gregor Steffen; Frank Waldfahrer; Reinhard Berner
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-02-16       Impact factor: 2.503

8.  Human beta-defensins--at the front line of the peritonsillar abscess.

Authors:  M Schwaab; S Hansen; M D Pearson; S Shagdarsuren; S Dazert
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-01-24       Impact factor: 3.267

9.  Cigarette Smoking Modulation of Saliva Microbial Composition and Cytokine Levels.

Authors:  Mary Rodríguez-Rabassa; Pablo López; Ronald E Rodríguez-Santiago; Antonio Cases; Marcos Felici; Raphael Sánchez; Yasuhiro Yamamura; Vanessa Rivera-Amill
Journal:  Int J Environ Res Public Health       Date:  2018-11-07       Impact factor: 3.390

10.  Isolated oropharyngeal abscess with hypopharyngeal extension recurring 12 years after initial surgical management: A case report and review of the literature.

Authors:  Michel Khoury; Selina Xiangxu Dong; Hussain Alsaffar; Stephanie Johnson-Obaseki; Lisa Caulley
Journal:  SAGE Open Med Case Rep       Date:  2022-04-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.